Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
Hematologic Oncology Update
00:00
Covalent BTK inhibitors: efficacy and long‑term data
Rogers reviews ibrutinib, acalabrutinib, and zanubrutinib efficacy, safety differences and long‑term PFS observations.
Play episode from 02:40
Transcript
